China SXT Pharmaceuticals (SXTC) Current Assets (2018 - 2025)

China SXT Pharmaceuticals' Current Assets history runs 8 years deep, the most recent figure standing at $26.0 million for Q3 2025.

• In Q3 2025, Current Assets rose 18.44% year-over-year to $26.0 million; the TTM figure through Sep 2025 stood at $26.0 million (up 18.44% YoY), while the FY2025 annual figure was $21.3 million, up 49.62% from the prior year.
• Current Assets was $26.0 million for Q3 2025 at China SXT Pharmaceuticals, up from $21.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $26.0 million in Q3 2025 to a low of $11.7 million in Q3 2021.
• Historically, Current Assets has averaged $18.6 million across 5 years, with a median of $20.4 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Current Assets sank 47.14% in 2021, then jumped 62.93% in 2024.
• A 5-year view of Current Assets shows it stood at $11.7 million in 2021, then advanced by 5.99% to $12.4 million in 2022, then grew by 9.19% to $13.5 million in 2023, then surged by 62.93% to $22.0 million in 2024, then gained by 18.44% to $26.0 million in 2025.
• The last three Current Assets figures came in at $26.0 million (Q3 2025), $21.3 million (Q1 2025), and $22.0 million (Q3 2024), per Business Quant data.